210 related articles for article (PubMed ID: 16174603)
1. Laboratory identification of familial thrombophilia: do the pitfalls exceed the benefits? A reassessment of ABO-blood group, gender, age, and other laboratory parameters on the potential influence on a diagnosis of protein C, protein S, and antithrombin deficiency and the potential high risk of a false positive diagnosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L
Lab Hematol; 2005; 11(3):174-84. PubMed ID: 16174603
[TBL] [Abstract][Full Text] [Related]
2. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance: the influence of ABO-blood group, gender and age.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L
Thromb Res; 2006; 117(6):665-70. PubMed ID: 16023702
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of thrombophilia based on coagulation and genetic studies].
Bałszan-Kowalska I
Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
[TBL] [Abstract][Full Text] [Related]
5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
6. External quality assessment and the laboratory diagnosis of thrombophilia.
Meijer P; Haverkate F
Semin Thromb Hemost; 2005 Feb; 31(1):59-65. PubMed ID: 15706476
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
8. Pro CR global: an effective screening test for thrombophilia.
Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
[TBL] [Abstract][Full Text] [Related]
9. [Hemostasis parameters in 55 patients with venous and/or arterial thromboembolisms].
Thommen D; Buhrfeind E; Felix R; Sulzer I; Furlan M; Lämmle B
Schweiz Med Wochenschr; 1989 Apr; 119(16):493-9. PubMed ID: 2524096
[TBL] [Abstract][Full Text] [Related]
10. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance issues and interpretation of assays.
Mackie I; Cooper P; Kitchen S
Semin Hematol; 2007 Apr; 44(2):114-25. PubMed ID: 17433904
[TBL] [Abstract][Full Text] [Related]
12. A clinical audit of congenital thrombophilia investigation in tertiary practice.
Favaloro EJ; Mohammed S; Pati N; Ho MY; McDonald D
Pathology; 2011 Apr; 43(3):266-72. PubMed ID: 21436638
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factor.
Favaloro EJ; Bonar R; Survela L; McDonald D; Koutts J; Sioufi J; Marsden K
Lab Hematol; 2007; 13(4):128-34. PubMed ID: 18192144
[TBL] [Abstract][Full Text] [Related]
14. Thrombophilia and unexplained pregnancy loss in Indian patients.
Vora S; Shetty S; Salvi V; Satoskar P; Ghosh K
Natl Med J India; 2008; 21(3):116-9. PubMed ID: 19004141
[TBL] [Abstract][Full Text] [Related]
15. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K;
Thromb Haemost; 2006 Jul; 96(1):73-8. PubMed ID: 16807654
[TBL] [Abstract][Full Text] [Related]
16. Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal status.
Franchi F; Biguzzi E; Martinelli I; Bucciarelli P; Palmucci C; D'Agostino S; Peyvandi F
Thromb Res; 2013 Aug; 132(2):e152-7. PubMed ID: 23920430
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic issues in thrombophilia: a laboratory scientist's view.
Favaloro EJ
Semin Thromb Hemost; 2005 Feb; 31(1):11-6. PubMed ID: 15706470
[TBL] [Abstract][Full Text] [Related]
18. New direct assay of free protein S antigen applied to diagnosis of protein S deficiency.
Aillaud MF; Pouymayou K; Brunet D; Parrot G; Alessi MC; Amiral J; Juhan-Vague I
Thromb Haemost; 1996 Feb; 75(2):283-5. PubMed ID: 8815577
[TBL] [Abstract][Full Text] [Related]
19. Danger of false negative (exclusion) or false positive (diagnosis) for 'congenital thrombophilia' in the age of anticoagulants.
Favaloro EJ
Clin Chem Lab Med; 2019 May; 57(6):873-882. PubMed ID: 30485173
[TBL] [Abstract][Full Text] [Related]
20. The anticoagulant potential of the protein C system in hereditary and acquired thrombophilia: pathomechanisms and new tools for assessing its clinical relevance.
Kraus M
Semin Thromb Hemost; 1998; 24(4):337-54. PubMed ID: 9763351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
